研報掘金丨華泰證券:維持工業富聯“買入”評級,上調目標價至35.6元
華泰證券研報指出,工業富聯預計1H25實現歸母淨利潤119.58~121.58億元(同比增長36.84%~39.12%);預計2Q25單季度實現歸母淨利潤67.27~69.27億元(同比增長47.72%~52.11%),扣非淨利潤66.94~68.94億元(同比增長57.10%~61.80%)。Q2公司利潤同比環比均實現顯著成長,創歷史同期新高,主要得益於大客戶GB200 服務器出貨加速推進以及800G 交換機放量。看好公司下半年延續快速成長趨勢,上調2025 年歸母淨利潤預期至303億,上調目標價至35.6元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.